ロード中...
Human papillomavirus vaccine initiation among 9–13-year-olds in the United States
The quadrivalent and 9-valent human papillomavirus (HPV) vaccines are licensed for administration among 9–26-year-old males and females, with routine vaccination recommended for 11–12-year-olds. Despite the availability of the vaccine at younger ages, few studies have explored vaccine uptake prior t...
保存先:
| 出版年: | Prev Med Rep |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4652326/ https://ncbi.nlm.nih.gov/pubmed/26594616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pmedr.2015.10.003 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|